Oragenics Inc (OGEN)
1.04
+0.05
(+5.05%)
USD |
NYAM |
Jun 28, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Oragenics SG&A Expense (TTM): 5.999M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 5.999M |
December 31, 2023 | 5.452M |
September 30, 2023 | 4.585M |
June 30, 2023 | 4.468M |
March 31, 2023 | 4.396M |
December 31, 2022 | 4.479M |
September 30, 2022 | 4.669M |
June 30, 2022 | 4.301M |
March 31, 2022 | 4.627M |
December 31, 2021 | 5.272M |
September 30, 2021 | 5.391M |
June 30, 2021 | 5.553M |
March 31, 2021 | 4.991M |
December 31, 2020 | 4.534M |
September 30, 2020 | 4.236M |
June 30, 2020 | 4.078M |
March 31, 2020 | 4.296M |
December 31, 2019 | 3.757M |
September 30, 2019 | 3.89M |
June 30, 2019 | 4.221M |
March 31, 2019 | 4.207M |
December 31, 2018 | 4.022M |
September 30, 2018 | 3.588M |
June 30, 2018 | 3.330M |
March 31, 2018 | 3.109M |
Date | Value |
---|---|
December 31, 2017 | 3.179M |
September 30, 2017 | 3.514M |
June 30, 2017 | 3.690M |
March 31, 2017 | 3.840M |
December 31, 2016 | 3.824M |
September 30, 2016 | 3.747M |
June 30, 2016 | 3.407M |
March 31, 2016 | 3.199M |
December 31, 2015 | 3.165M |
September 30, 2015 | 3.122M |
June 30, 2015 | 2.925M |
March 31, 2015 | 3.370M |
December 31, 2014 | 3.322M |
September 30, 2014 | 4.869M |
June 30, 2014 | 6.862M |
March 31, 2014 | 7.204M |
December 31, 2013 | 7.540M |
September 30, 2013 | 6.465M |
June 30, 2013 | 5.504M |
March 31, 2013 | 4.820M |
December 31, 2012 | 5.025M |
September 30, 2012 | 4.954M |
June 30, 2012 | 4.722M |
March 31, 2012 | 5.579M |
December 31, 2011 | 5.628M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
3.757M
Minimum
Dec 2019
5.999M
Maximum
Mar 2024
4.683M
Average
4.534M
Median
Dec 2020
SG&A Expense (TTM) Benchmarks
GT Biopharma Inc | 7.409M |
ACADIA Pharmaceuticals Inc | 413.31M |
Ionis Pharmaceuticals Inc | 239.74M |
Cassava Sciences Inc | 15.84M |
Vertex Pharmaceuticals Inc | 1.238B |